[1] 陈祥, 周剑良, 张翔, 等.  宫颈癌三维后装治疗插植针路径优化的可行性研究[J]. 中华放射肿瘤学杂志, 2020, 29(3): 215-219.   doi: 10.3760/cma.j.issn.1004-4221.2020.03.013
Chen X, Zhou JL, Zhang X, et al.  Study of the feasibility of needle path optimization in 3D brachytherapy for cervical cancer[J]. Chin J Radiat Oncol, 2020, 29(3): 215-219.   doi: 10.3760/cma.j.issn.1004-4221.2020.03.013
[2] 郑斯明, 白玉海, 刘晓东, 等.  CT引导下三管式腔内后装与腔内结合插植后装用于宫颈癌治疗的对比研究[J]. 现代肿瘤医学, 2019, 27(22): 4077-4080.   doi: 10.3969/j.issn.1672-4992.2019.22.033
Zheng SM, Bai YH, Liu XD, et al.  A comparative study of the CT-guided three tube intracavitary brachytherapy and intracavitary/interstitial brachytherapy for cervical cancer[J]. J Mod Oncol, 2019, 27(22): 4077-4080.   doi: 10.3969/j.issn.1672-4992.2019.22.033
[3] Hanania AN, Myers P, Yoder AK, et al.  Inversely and adaptively planned interstitial brachytherapy: a single implant approach[J]. Gynecol Oncol, 2019, 152(2): 353-360.   doi: 10.1016/j.ygyno.2018.11.020
[4] Pecorelli S, Zigliani L, Odicino F.  Revised FIGO staging for carcinoma of the cervix[J]. Int J Gynaecol Obstet, 2009, 105(2): 107-108.   doi: 10.1016/j.ijgo.2009.02.009
[5] Pötter R, Haie-Meder C, Van Limbergen E, et al.  Recommendations from gynaecological (GYN) GEC ESTRO Working Group (Ⅱ): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology[J]. Radiother Oncol, 2006, 78(1): 67-77.   doi: 10.1016/j.radonc.2005.11.014
[6] Petrič P, Hudej R, Rogelj P, et al.  Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study[J]. Radiother Oncol, 2013, 107(1): 6-12.   doi: 10.1016/j.radonc.2013.01.014
[7] Palmqvist T, Wanderås AD, Marthinsen ABL, et al.  Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer[J]. Acta Oncol, 2014, 53(8): 1012-1018.   doi: 10.3109/0284186X.2014.928829
[8] Kim Y, Kim YJ, Kim JY, et al.  Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer[J]. Brachytherapy, 2017, 16(1): 116-125.   doi: 10.1016/j.brachy.2016.10.005
[9] Viswanathan AN, Cormack R, Rawal B, et al.  Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage ⅢB cervical cancer[J]. Int J Gynecol Cancer, 2009, 19(8): 1402-1406.   doi: 10.1111/IGC.0b013e3181b62e73
[10] Tan LT, Pötter R, Sturdza A, et al.  Change in patterns of failure after image-guided brachytherapy for cervical cancer: analysis from the retroEMBRACE study[J]. Int J Radiat Oncol Biol Phys, 2019, 104(4): 895-902.   doi: 10.1016/j.ijrobp.2019.03.038
[11] Li JP, Meng X, Dang YZ, et al.  Pure interstital brachytherapy using 3D-printed vaginal template for improved catheter tracks in treating cervical cancer[J]. J Biomater Tissue Eng, 2017, 7(6): 499-503.   doi: 10.1166/jbt.2017.1591
[12] Tanderup K, Fokdal LU, Sturdza A, et al.  Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer[J]. Radiother Oncol, 2016, 120(3): 441-446.   doi: 10.1016/j.radonc.2016.05.014
[13] 赵红福, 韩东梅, 程光惠, 等.  ICRU89号报告的解读——放射物理篇[J]. 中华放射肿瘤学杂志, 2019, 28(1): 74-77.   doi: 10.3760/cma.j.issn.1004-4221.2019.01.016
Zhao HF, Han DM, Cheng GH, et al.  Interpretation of ICRU report No. 89—radiation physics[J]. Chin J Radiat Oncol, 2019, 28(1): 74-77.   doi: 10.3760/cma.j.issn.1004-4221.2019.01.016
[14] Nomden CN, de Leeuw AAC, Moerland MA, et al.  Clinical use of the utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 82(4): 1424-1430.   doi: 10.1016/j.ijrobp.2011.04.044
[15] 张宁, 赵志鹏, 程光惠, 等.  局部晚期宫颈癌腔内联合组织间插植3D-IGBT的剂量学研究[J]. 中华放射肿瘤学杂志, 2015, 24(3): 267-270.   doi: 10.3760/cma.j.issn.1004-4221.2015.03.009
Zhang N, Zhao ZP, Cheng GH, et al.  Dosimetric study of three-dimensional image-guided brachytherapy combined with intracavitary/interstitial brachytherapy in locally advanced cervical cancer[J]. Chin J Radiat Oncol, 2015, 24(3): 267-270.   doi: 10.3760/cma.j.issn.1004-4221.2015.03.009
[16] Wakatsuki M, Ohno T, Yoshida D, et al.  Intracavitary combined with CT-guided interstitial brachytherapy for locally advanced uterine cervical cancer: introduction of the technique and a case presentation[J]. J Radiat Res, 2011, 52(1): 54-58.   doi: 10.1269/jrr.10091
[17] Harmon G, Diak A, Shea SM, et al.  Point A vs. HR-CTV D90 in MRI-based cervical brachytherapy of small and large lesions[J]. Brachytherapy, 2016, 15(6): 825-831.   doi: 10.1016/j.brachy.2016.08.010
[18] 周解平, 吴爱东, 钱立庭, 等.  宫颈癌三维后装治疗中两种优化方式的剂量及相关性分析[J]. 安徽医科大学学报, 2018, 53(10): 1598-1601.   doi: 10.19405/j.cnki.issn1000-1492.2018.10.023
Zhou JP, Wu AD, Qian LT, et al.  The dose and correlation analysis of two optimization methods in 3D intracavitary brachytherapy for cervical cancer[J]. Acta Univ Med Anhui, 2018, 53(10): 1598-1601.   doi: 10.19405/j.cnki.issn1000-1492.2018.10.023
[19] Yoshida K, Yamazaki H, Kotsuma T, et al.  Simulation analysis of optimized brachytherapy for uterine cervical cancer: can we select the best brachytherapy modality depending on tumor size?[J]. Brachytherapy, 2016, 15(1): 57-64.   doi: 10.1016/j.brachy.2015.10.002